FHAS Earns URAC Accreditation for Health Utilization Management in Clinical Reviews

July 02, 2025 11:20 AM PDT | By EIN Presswire
 FHAS Earns URAC Accreditation for Health Utilization Management in Clinical Reviews
Image source: EIN Presswire

WILKES-BARRE, PA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Federal Hearings & Appeals Services (FHAS), a national leader in medical review and dispute resolution services, announced today that it has earned URAC provisional accreditation in Health Utilization Management, which encompasses Pre-Review Screening, Initial Clinical Review, and Clinical Decision making. URAC is a leading independent healthcare accreditation body known for promoting healthcare quality through leadership, accreditation, measurement, and innovation.

By achieving this milestone, FHAS demonstrates its continued commitment to clinical excellence, operational transparency, and a continuous focus on improving healthcare outcomes.

“Achieving URAC’s HUM accreditation underscores our dedication to delivering fair, impartial, and efficient healthcare review services,” said Jim Bobeck, Esq., CEO of FHAS. “It reinforces our superior, all-encompassing UM services from prior authorization to case management and claims review services—clients partner with FHAS for operational excellence.”

After reviewing FHAS’ policies, procedures, workflows, and other organizational information, URAC has affirmed that FHAS meets the rigorous national standards in utilization management and is equipped to deliver high-quality, evidence-based services that promote fair and timely decisions for patients, providers, and payors alike.

“Appropriateness and efficiency are words to live by in meeting new value-based goals for population health. FHAS’ URAC accreditation shows an ability to abide by the gold standard when it comes to performing Health Utilization Management functions,” said URAC President and CEO Shawn Griffin, M.D. “URAC’s utilization management accreditation standards promote an evidence-based and reasonable review of services that respect both patients and providers.”

The provisional accreditation marks a significant step in FHAS’s mission to support the U.S. healthcare system with unbiased, high-quality medical reviews that meet the evolving needs of government agencies, health plans, and third-party administrators.

About FHAS
FHAS, a URAC-accredited Independent Review Organization (IRO), is a trusted national leader in dispute resolution, medical claims and appeals reviews, legal adjudication services, utilization management reviews, and business process outsourcing. As the industry’s premier Independent Dispute Resolution Entity (IDRE) and a leading medical claims review partner, FHAS leverages nearly 30 years of expertise to deliver fair, accurate, and timely solutions for healthcare providers, payors, federal and state government agencies, and industry vendors supporting government-subsidized programs. FHAS operates at the intersection of healthcare, regulation, and government programs, supporting payers and public agencies in delivering fair, evidence-based outcomes.

About URAC
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement, and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices, and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.

Michael Deckman
Federal Hearings and Appeals Services, LLC
+1 570-550-4466
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next